107.521 articles found

The hallucinations experienced by patients with idiopathic Parkinson's disease

Graham JM.

· 2001-01-01

Optimisation of neural transplantation for Parkinson's and Huntington's diseases

Hurelbrink CB.

· 2001-01-01

Mapping self-management strategies in Parkinson's disease : implications for physiotherapy practice and research

Jones D.

· 2001-01-01

Quantitative and qualitative evaluation of drug-induced Parkinsonism

Dobson MJ.

· 2001-01-01

Treatment of Parkinson^s disease by genetically modified immortalized fibroblasts

Xu Dehua, Chen Xianwen, Xu Lingfei, Cao Lei, Chen Shengdi, Liu Xinyuan, Zheng Zhongcheng.

Acta Biochimica et Biophysica Sinica · 2001-01-01

A study on differentially-expressed genes in the substantia nigra from a MPTP-induced monkey model of Parkinson disease

Yang Youwen, Duan Deyi, Zhang Jinlu, Sun Gaoge, Liu Yujun, Man Ruixin, Xu Qunyuan.

Acta Anatomica Sinica · 2001-01-01

Triple transduction of dopamine biosynthetic enzyme genes for Parkinsonian rats

Shen Yang, Fan Dongsheng, Wang Lijun, Kang Dexuan.

Chinese Journal of Physical Medicine · 2001-01-01

Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Yang Sufen, Yang Zhengxin, Wu Qin, Sun Ansheng, Huang Xienab, Shi Jingshan.

Zhongguo yao li xue bao = Acta pharmacologica Sinica · 2001-01-01

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

Murer MG, Yan Q, Raisman-Vozari R.

Prog Neurobiol · 2001-01-01

DOI: 10.1016/s0301-0082(00)00014-9PMID: 11040419

High-frequency oscillations in human posterior tibial somatosensory evoked potentials are enhanced in patients with Parkinson's disease and multiple system atrophy.

Inoue K, Hashimoto I, Nakamura S.

Neurosci Lett · 2001-01-01

DOI: 10.1016/s0304-3940(00)01678-5PMID: 11121877

The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma.

Guridi J, Obeso JA.

Brain · 2001-01-01

DOI: 10.1093/brain/124.1.5PMID: 11133783

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.

Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jäkälä P, Beyreuther K, Masters CL, Li QX.

J Neurochem · 2001-01-01

DOI: 10.1046/j.1471-4159.2001.00021.xPMID: 11145981